A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS

This study is ongoing, but not recruiting participants.

Study NCT00002384. Last updated on June 23, 2005. Information provided by NIH AIDS Clinical Trials Information Service

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields
Brief Title ^†	A Study of Cidofovir in the Treatment of Cytomegalovirus (CMV) of the Eyes in Patients With AIDS
Official Title ^†	Vistide (Cidofovir Intravenous) Treatment IND Protocol for Relapsing Cytomegalovirus Retinitis in Patients With AIDS
Brief Summary	Incomplete Closed Protocol
Detailed Description
Study Phase
Study Type ^†	Interventional
Study Design ^†	Treatment
Primary Outcome Measure ^†
Secondary Outcome Measure ^†
Condition ^†	Cytomegalovirus Retinitis HIV Infections
Intervention ^†	Drug: Cidofovir
MEDLINE PMIDs
Links

Recruitment Information Fields
Recruitment Status ^†	Active, not recruiting
Enrollment ^†
Start Date ^†
Completion Date
Eligibility Criteria ^†	Information not available
Gender	Both
Ages	13 Years and older
Accepts Healthy Volunteers	No
Contacts ^††
Location Countries ^†

Administrative Information Fields
NCT ID ^†	NCT00002384
Organization ID	276A
Secondary IDs ^††	GS-95-120, 96ACR-GIL1
Study Sponsor ^†	Gilead Sciences
Collaborators ^††	Anderson Clinical Research
Investigators ^†
Information Provided By	NIH AIDS Clinical Trials Information Service
Verification Date	August 1997
First Received Date ^†	November 2, 1999
Last Updated Date	June 23, 2005

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.